The development of drotrecogin alfa (activated) for the treatment of severe sepsis

被引：2
|
作者：
Macias, WL [1 ]
Yan, SB [1 ]
Grinnell, BW [1 ]
机构：
[1] Eli Lilly & Co, Lilly Lab Clin Res, Indianapolis, IN 46285 USA
来源：
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS | 2004年 / 27卷 / 05期
关键词：
D O I：
10.1177/039139880402700504
中图分类号：
R318 [生物医学工程];
学科分类号：
0831 ;
摘要：
[No abstract available]
引用
收藏
页码：360 / 370
页数：11
相关论文
共 50 条
  • [1] Drotrecogin alfa (activated): the treatment for severe sepsis?
    Vincent, Jean-Louis
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2007, 7 (11) : 1763 - 1777
  • [2] Drotrecogin Alfa (Activated) in the Treatment of Severe Sepsis
    Vincent, Jean-Louis
    [J]. CURRENT DRUG SAFETY, 2007, 2 (03) : 227 - 231
  • [3] Timing of drotrecogin alfa (activated) treatment in severe sepsis
    Choi, Goda
    de Pont, Anne-Cornelie J. M.
    Schultz, Marcus J.
    [J]. CRITICAL CARE, 2006, 10 (04):
  • [4] Timing of drotrecogin alfa (activated) treatment in severe sepsis
    Goda Choi
    Anne-Cornélie JM de Pont
    Marcus J Schultz
    [J]. Critical Care, 10
  • [5] Drotrecogin alfa (activated) in severe sepsis
    Baillie, JK
    Murray, G
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (01): : 95 - 95
  • [6] Drotrecogin alfa (activated) in severe sepsis
    Janes, Jonathan M.
    Vangerow, Burkhard
    Costigan, Timothy M.
    Macias, William L.
    [J]. LANCET INFECTIOUS DISEASES, 2013, 13 (02): : 108 - 109
  • [7] Drotrecogin alfa (Activated) for the treatment of severe sepsis and septic shock
    Rice, TW
    Bernard, GR
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2004, 328 (04): : 205 - 214
  • [8] Drotrecogin alfa (activated) treatment of older patients with severe sepsis
    Ely, EW
    Angus, DC
    Williams, MD
    Bates, B
    Qualy, R
    Bernard, GR
    [J]. CLINICAL INFECTIOUS DISEASES, 2003, 37 (02) : 187 - 195
  • [9] Drotrecogin alfa activated as a treatment for severe sepsis in pediatric cancer
    Russo, G.
    La Spina, M.
    Disma, N.
    Astuto, M.
    [J]. BONE MARROW TRANSPLANTATION, 2006, 38 (08) : 575 - 576
  • [10] The efficacy of drotrecogin alfa (activated) for the treatment of pediatric severe sepsis
    Giroir, B
    Goldstein, B
    Nadel, S
    Wang, DZ
    Levy, H
    Williams, M
    [J]. CRITICAL CARE MEDICINE, 2005, 33 (12) : A152 - A152
12345